Shares in International Biotechnology Trust (LON:IBT) were boosted by the news portfolio company Crinetics Pharmaceuticals (NASDAQ:CRNX) has been acquired by Vertex Pharmaceuticals (NASDAQ:VRTX). IBT managers Ailsa Craig and Marek Poszepczynski have a real knack for spotting takeover targets. Amazingly, the Crinetics takeover marks the eighth acquisition within the trust’s portfolio in 2026-to-date. These include the … Continue reading International Biotechnology Trust receives another shot in the arm